Sai Parenterals Reports No IPO Fund Deviation Q1 FY27

Key Finding

There are no deviation(s) or variation(s) in respect of the utilization of the proceeds of the Initial Public Offer (IPO) of the Company during the quarter ended June 30, 2026.

Financial Details of IPO Fund Utilization

General Corporate Purposes

• Amount Allocated: ₹447.40 lakhs
• Amount Utilized: ₹189.90 lakhs
• Deviation/Variation: Not Applicable (No deviation)
• % Utilized: 42.45% of allocated amount

Issue Expenses

• Amount Allocated: ₹284.99 lakhs
• Amount Utilized: ₹284.99 lakhs
• Deviation/Variation: Not Applicable (No deviation)
• % Utilized: 100% of allocated amount

Signing Authority

The document is digitally signed by Mr. Anil Kumar Karusala, Managing Director (DIN: 01866646) on August 11, 2026 at 17:41:51 IST.